James J. Buchanan

Family Medicine

6600 Bruceville Rd
2nd Floor
Sacramento, CA 95823

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

A Large Language Model for Extracting Post-marketing Adverse Drug Events from Clinical Notes in the Electronic Health Record.

A Large Language Model for Extracting Post-marketing Adverse Drug Events from Clinical Notes in the Electronic Health Record.

Journal: Drug safety

Published: December 07, 2025

Applying Aggregate Statistical Analyses to Safety Monitoring of Ongoing Clinical Studies, Issues, and Opportunities in a Test Case.

Applying Aggregate Statistical Analyses to Safety Monitoring of Ongoing Clinical Studies, Issues, and Opportunities in a Test Case.

Journal: Therapeutic innovation & regulatory science

Published: December 18, 2024

Algorithmic identification of treatment-emergent adverse events from clinical notes using large language models: a pilot study in inflammatory bowel disease.

Algorithmic identification of treatment-emergent adverse events from clinical notes using large language models: a pilot study in inflammatory bowel disease.

Journal: medRxiv : the preprint server for health sciences

Published: September 21, 2023

Algorithmic Identification of Treatment-Emergent Adverse Events From Clinical Notes Using Large Language Models: A Pilot Study in Inflammatory Bowel Disease.

Algorithmic Identification of Treatment-Emergent Adverse Events From Clinical Notes Using Large Language Models: A Pilot Study in Inflammatory Bowel Disease.

Journal: Clinical pharmacology and therapeutics

Published: September 12, 2023

Assessing adverse events in clinical trials during the era of the COVID-19 pandemic.

Assessing adverse events in clinical trials during the era of the COVID-19 pandemic.

Journal: Journal of biopharmaceutical statistics

Published: January 31, 2023

Important Considerations for Signal Detection and Evaluation.

Important Considerations for Signal Detection and Evaluation.

Journal: Therapeutic innovation & regulatory science

Published: December 04, 2022

A New Paradigm for Safety Data Signal Detection and Evaluation Using Open-Source Software Created by an Interdisciplinary Working Group.

A New Paradigm for Safety Data Signal Detection and Evaluation Using Open-Source Software Created by an Interdisciplinary Working Group.

Journal: Therapeutic innovation & regulatory science

Published: February 04, 2021

Interdisciplinary Safety Evaluation for Learning and Decision-Making.

Interdisciplinary Safety Evaluation for Learning and Decision-Making.

Journal: Therapeutic innovation & regulatory science

Published: October 07, 2020

A Framework for Safety Evaluation Throughout the Product Development Life-Cycle.

A Framework for Safety Evaluation Throughout the Product Development Life-Cycle.

Journal: Therapeutic innovation & regulatory science

Published: September 05, 2019

Global Regulatory Landscape for Aggregate Safety Assessments: Recent Developments and Future Directions.

Global Regulatory Landscape for Aggregate Safety Assessments: Recent Developments and Future Directions.

Journal: Therapeutic innovation & regulatory science

Published: November 16, 2018

Safety and tolerability of etirinotecan pegol in advanced breast cancer: analysis of the randomized, phase 3 BEACON trial.

Safety and tolerability of etirinotecan pegol in advanced breast cancer: analysis of the randomized, phase 3 BEACON trial.

Journal: SpringerPlus

Published: May 16, 2016

Showing 1-11 of 11

Last Updated: 09/26/2026